Sirajudeen S. Alavudeen
King Khalid University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sirajudeen S. Alavudeen.
Journal of applied pharmacy | 2015
Noohu Abdulla Khan; V.v. Venkatachalam; Khaled M. Al Akhali; Sirajudeen S. Alavudeen; C. K. Dhanapal; Asif Ansari Shaik Mohammad
Background: Knowledge, awareness is the greatest weapon in the fight against diabetes mellitus. It can help the people understand the risk of diabetes, motivate them to seek proper treatment and care, and prepare them to keep the disease under control. Objective: To assess the overview about glycemic control knowledge, attitude and awareness among the T2 DM male patients towards Diabetes. Methods: Single center cross sectional, retrospective cum prospective study conducted at Aseer diabetic center, Abha, from July, 2012 to October 2013 to assess the glycemic control knowledge, attitude and awareness. Results: In this current study only 15.12% of patients and had awareness about their type of DM, and 35.12% of patients had knowledge about DM. As a the therapeutic outcome the patients had an average HbA1c value of 9.17(±1.68) % and BMI of 28.52(±5.00) kg/m2. Conclusion: Present study outcomes indicate that the improvement in diabetic patient’s knowledge, awareness and attitude about the disease can do productive changes in the gylcemic control
International research journal of pharmacy | 2015
M Mohammad Ahmad Awwad Al-qahtani; N Noohu Abdulla Kan; K Khaled. M. Alakhali; Sirajudeen S. Alavudeen
There is a significant increase in the inc idence and prevalence of Dia betes Mellitus (DM) worldwide and in the Kingdom of Saudi Arabia (KSA) . Various studies have been shown the relevance of genetic factor in the onset of type - 2 diabetes mellitus (T2DM) . In this view the study has been conducted t o find the correlation between family history and glycemic control among the T2 DM patients in Aseer Diabetic C enter (ADC) , Abha KSA . This is a cross sectional retrospective study . A total of 343 patients medical records were accessed to evaluate the role of family history in g lycemic control. For the purpose of the study patients were randomly selected and divided into four groups (I - without family history; II - with first degree family history; III - with second degree family history and IV - with both first an d second degree family history). The HbA1c value was considered as primary outcome measure in each group. In addition to this other factors such as age, duration of DM, BMI (Body Mass Index) were also studied. Among this study population, about 54.81 % of patients had positive 1 st degree family history. The mean age for patients without family history is 62.19 (± 9.29) yrs and 59.98 (± 10.39) for patients with family history, which shows that occurring of DM is early in positive family history groups. The H bA1c value in patients without family history and with family history in either sex is not significant ( p < 0.39). In our study, HbA1c levels show no significant difference between patients with and without family history. In concl usion the family history plays no significant role in glycemic control in T2DM patients in ADC.
Ars Pharmaceutica (Internet) | 2015
Sirajudeen S. Alavudeen; K Khaled. M. Alakhali; Shaik Mohammad Asif Ansari; Noohu Abdulla Khan
Background. Hypertension is extremely prevalent in patients with diabetes. Limited data exist on utilizationpatterns of antihypertensive in this population are consistent with evidence-based practice guidelines. Objective. To evaluate utilization patterns of antihypertensive agents among diabetic patients with hypertension. Design. Retrospective descriptive cross sectional. Patients / Participants. 149 patients with diabetes and hypertension from outpatient department at FamilyMedicine Hospital, Ahaderfieda. Khamis Mushait, K.S.A. Results. Over 43% of patients were receiving calcium channel blockers (CCB), 36.2 % of received angiotensinconverting enzyme inhibitors (ACEI), followed by angiotensin receptor blockers (ARBs) (34.9%),diuretics (34.2%) and β -blockers (16.2%). Patients on monotherapy were mostly receiving CCB (34.3%)and ACEI (29.9%). The majority (55.03%) of treated patients were on multidrug regimens. In patientswith coronary artery disease (CAD), a diuretic with ACEI (25%) and calcium channel blocker with angiotensinreceptor blocker (25%) was most commonly prescribed. Conclusions. Patterns of antihypertensive therapy were generally consistent with international guidelines.Areas of improvement include increasing ACEI/ARB and diuretic use, decreasing the number ofuntreated patients, and increasing the proportion of patients with controlled BP in this population.
Journal of Young Pharmacists | 2013
Sirajudeen S. Alavudeen; C. K. Dhanapal; Noohu Abdulla Khan; Khalid M. Al Akhali; Sam Daniel Paulliah
Asian Journal of Pharmaceutics | 2014
Khaled M. Al Akhali; Sirajudeen S. Alavudeen
Asian Journal of Pharmaceutical and Clinical Research | 2014
Noohu Abdulla Khan; V.v. Venkatachalam; K Khaled. M. Alakhali; Sirajudeen S. Alavudeen; Dhanapal C.K; Shaik Mohammad Asif Ansari
Journal of Young Pharmacists | 2017
Sirajudeen S. Alavudeen; Easwaran Vigneshwaran; Sultana Ali Abdullah Asiri; Manal Hamood Awad Alahmari; Maha Abdullah Mohammed; Thikra Algahtani; Noohu Abdullah Khan
Archive | 2014
Noohu Abdulla Khan; V.v. Venkatachalam; Sirajudeen S. Alavudeen; K Khaled. M. Alakhali; D C K Dhanapal
Archive | 2014
Sirajudeen S. Alavudeen; D Dr.C.K Dhanapal; K Dr.Khaled M.Al Akhali; Noohu Abdulla Khan; Dr.V.V.Venkatachalam
Archive | 2014
Noohu Abdulla Khan; V.v. Venkatachalam; Sirajudeen S. Alavudeen; D C.K.Dhanapal; S Sam Daniel Pauliah; Khaled M. Al Akhali